MRKR
Marker Therapeutics·NASDAQ
--
--(--)
--
--(--)
MRKR fundamentals
Marker Therapeutics (MRKR) released its earnings on Nov 13, 2025: revenue was 1.23M (YoY -35.99%), beat estimates; EPS was -0.12 (YoY +53.85%), beat estimates.
Revenue / YoY
1.23M
-35.99%
EPS / YoY
-0.12
+53.85%
Report date
Nov 13, 2025
Earnings
EPS
Revenue
Revenue & Expenses
MRKR has released its 2025 Q4 earnings report, with revenue of 1.10M, reflecting a YoY change of -51.00%, and net profit of -1.70M, showing a YoY change of 55.62%. The Sankey diagram below clearly presents MRKR's revenue sources and cost distribution.
Key Indicators
Marker Therapeutics (MRKR) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Marker Therapeutics (MRKR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Marker Therapeutics (MRKR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Marker Therapeutics (MRKR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Marker Therapeutics (MRKR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Marker Therapeutics (MRKR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Marker Therapeutics do and what are its main business segments?What factors drove the changes in Marker Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Marker Therapeutics year over year?What guidance did Marker Therapeutics's management provide for the next earnings period?What were the key takeaways from Marker Therapeutics's earnings call?Did Marker Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Marker Therapeutics’s earnings call?What is the market's earnings forecast for Marker Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
